Brinda Balakrishnan, Director of Aurinia Pharmaceuticals AUPH, has filed 0 purchases and 1 sale on the open market. The latest trade was on 24/05/21.

BB

BB

Brinda Balakrishnan

Director

Company

Aurinia Pharmaceuticals AUPH

First filing

23/05/23

Trades

5 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

24/05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aurinia PharmaceuticalsAUPH	Open-market sale	24/05/21	24/05/22	520 sh	$5.74	$2,984.8	−2.9%